The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant: Fran Hawthorne

From The New England Journal of Medicine
Few industries have guarded information about their products and finances as closely as U.S. drug manufacturers have. These manufacturers have built almost impregnable walls around their pharmaceutical formulas and financial data, which include information about expenditures on research and development and [...]

Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science: Yali Friedman

Review
… a sound foundation for better understanding this exciting and rapidly changing line of commerce. — RiskWorld
… an impressive compendium of information for people getting started in the biotechnology industry. — BioExecutive International, January 2005
…a robust, commercially-oriented readable book which should be read not only by specialists [...]

Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies - Business Development, Entrepreneurship, Careers, Investing, Science, Patents and Regulations: Yali Friedman

Review
… a sound foundation for better understanding this exciting and rapidly changing line of commerce. — RiskWorld
A terrific, plain-language introduction to a growing entrepreneurial sector. — National Business Incubation Association
Building Biotechnology helps readers start and manage biotechnology companies and understand the [...]

It’s Alive: The Coming Convergence of Information, Biology, and Business: Christopher Meyer, Stan Davis

Editorial Reviews
From Publishers Weekly
The hackneyed trope of businesses as organisms in an economic ecosystem is updated in this informative but puffed-up volume of management theory. According to Meyer and Davis, authors of the New Economy manifesto Blur: The Speed of Change in the Connected Economy, the next [...]

Valuation in Life Sciences: A Practical Guide: Boris Bogdan, Ralph Villiger

Editorial Reviews
Review
From the reviews: “‘Valuation in Life Sciences: A Practical Guide’ leads readers step by step through the theory of life sciences valuation. … it is an important read for biotech investors. … It is the first book of its kind that combines industry [...]

Creative Capital: Georges Doriot and the Birth of Venture Capital: Spencer E. Ante

Editorial Reviews
Review
An "ultimately satisfying biography of Georges F. Doriot, the transplanted Frenchman who is often called the father of V.C." –The New York Times, June 1, 2008
Richly researched with the cooperation of Doriot’s surviving colleagues… –The Wall Street Journal, May 21, 2008
This book will appeal to anyone [...]

The Biotech Investor’s Bible: George Wolff

Editorial Reviews
Product Description
A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today’s most promising (and volatile) industries To invest in biotech is to invest in the future, and as such, investors [...]

It’s Alive: The Coming Convergence of Information, Biology, and Business: Christopher Meyer, Stan Davis

Editorial Reviews
From Publishers Weekly
The hackneyed trope of businesses as organisms in an economic ecosystem is updated in this informative but puffed-up volume of management theory. According to Meyer and Davis, authors of the New Economy manifesto Blur: The Speed of Change in the Connected Economy, the next [...]

Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices: Shreefal S. Mehta

Editorial Reviews
Review
“This new text covers the commercialization of life science technologies widely, ranging across the spectrum of pharmaceuticals, biotechnologies, medical devices and diagnostics and spanning the development process from invention through marketing and sales. Shreefal Mehta writes clearly and with a practical bent, using case [...]

The Transparent Leader: How to Build a Great Company Through Straight Talk, Openness, and Accountability: Herb Baum, Tammy Kling

Editorial Reviews
From Publishers Weekly
To restore consumer trust in American companies and products, Baum, chairman, president and CEO of Dial Corporation, believes that all executives must adopt a “transparent” style of leadership: honest accountability upstairs, a value-based company culture throughout and employees who are service oriented. Writing with [...]